B

Active Director Director DIN 07245571
DIN 07245571 First appointment Mar 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Mar 2015
Shareholding value •••• Premium profile

About Bhawarlal

Data last updated:

Bhawarlal is a Director at Trigenesis Lifesciences Private Limited (since 2019), Director at Trigenesis Biosciences Private Limited (since 2020) and Director at Avinya Lifesciences Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma and Trading. The 4 current companies with reported revenue have a combined latest revenue of ₹1.59 Cr; the largest is Trigenesis Lifesciences Private Limited at ₹1.44 Cr (FY 2025). Earlier, Bhawarlal was a Director at Plasmagen Biosciences Private Limited (2015–2023).

DIN 07245571
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2015
Oldest Company Age 22 yrs
Largest company Trigenesis Lifesciences Private Limited · ₹1.44 Cr (FY 2025)
Combined revenue ₹1.59 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Dec 20192004₹1.44 Cr (FY 2025)Active
Director16 Sep 20202011₹12.6 Lakh (FY 2022)Active
Avinya Lifesciences Private Limited U74999KA2018PTC110215
Director01 Apr 20212018₹1.2 Lakh (FY 2025)Active
Lifelong Biological Private Limited U24239KA2007PTC043662
Director29 Dec 20222007₹82,791 (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20152010₹162 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Trigenesis Lifesciences Private Limited
Trigenesis Biosciences Private Limited
Avinya Lifesciences Private Limited
Lifelong Biological Private Limited
Premium access

Shareholding and investment profile for Bhawarlal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhawarlal

Bhawarlal currently holds 4 directorships: Trigenesis Lifesciences Private Limited (Director, since 16 Dec 2019, revenue ₹1.44 Cr (FY 2025)); Trigenesis Biosciences Private Limited (Director, since 16 Sep 2020, revenue ₹12.6 Lakh (FY 2022)); Avinya Lifesciences Private Limited (Director, since 01 Apr 2021, revenue ₹1.2 Lakh (FY 2025)); Lifelong Biological Private Limited (Director, since 29 Dec 2022, revenue ₹82,791 (FY 2025)).

Bhawarlal was first appointed on 31 Mar 2015 as Director at Plasmagen Biosciences Private Limited. The most recent appointment on record is 29 Dec 2022 at Lifelong Biological Private Limited.

The 4 current companies of Bhawarlal that report revenue have a combined latest revenue of ₹1.59 Cr: Trigenesis Lifesciences Private Limited ₹1.44 Cr (FY 2025); Trigenesis Biosciences Private Limited ₹12.6 Lakh (FY 2022); Avinya Lifesciences Private Limited ₹1.2 Lakh (FY 2025); Lifelong Biological Private Limited ₹82,791 (FY 2025).

Bhawarlal held 1 earlier board appointment: Plasmagen Biosciences Private Limited (Director, 31 Mar 2015 to 14 Apr 2023).

The current boards of Bhawarlal's companies include Vijay Nahar (Trigenesis Lifesciences Private Limited), Bhavik Nirmal Jain (Avinya Lifesciences Private Limited), Nirmal Lalchand Jain (Avinya Lifesciences Private Limited), Sonu Dantewadia (Avinya Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available